Article
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jan 2009
Büchner Thomas, Berdel Wolfgang E, Haferlach Claudia, Haferlach Torsten, Schnittger Susanne, Müller-Tidow Carsten, Braess Jan, Spiekermann Karsten, Kienast Joachim, Staib Peter, Grüneisen Andreas, Kern Wolfgang, Reichle Albrecht, Maschmeyer Georg, Aul Carlo, Lengfelder Eva, Sauerland Maria-Cristina, Heinecke Achim, Wörmann Bernhard, Hiddemann Wolfgang
Abstract excerpt
PURPOSE: The purpose of the study was to assess the contribution of age and disease variables to the outcome of untreated patients with acute myeloid leukemia (AML) receiving varying intensive induction chemotherapy. PATIENTS AND METHODS: Patients 16 to 85 years of age with primary AML, known karyotype, and uniform postremission chemotherapy enrolled onto two consecutive trials were eligible and were randomly...
Topics
- Adolescent
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Dose-Response Relationship, Drug
- Female
- Humans
